UPDATE: Morgan Stanley Downgrades Atea Pharmaceuticals (AVIR) to Equalweight
Tweet Send to a Friend
(Updated - October 5, 2021 4:58 AM EDT)
Morgan Stanley analyst Matthew Harrison downgraded Atea Pharmaceuticals (NASDAQ: AVIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison downgraded Atea Pharmaceuticals (NASDAQ: AVIR) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
